Antidepressant treatment of depression: A metaanalysis

被引:85
作者
Joffe, R [1 ]
Sokolov, S [1 ]
Streiner, D [1 ]
机构
[1] MCMASTER UNIV,DEPT CLIN EPIDEMIOL & BIOSTAT,HAMILTON,ON L8N 3Z5,CANADA
来源
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE | 1996年 / 41卷 / 10期
关键词
depression; metaanalysis; antidepressant;
D O I
10.1177/070674379604101002
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: To carry out a metaanalysis of antidepressant studies to calculate the effect sizes for antidepressant effect in depressive disorder. Method: A metaanalysis of all antidepressant studies that included an active comparison drug as well as placebo was used to calculate the effect size. Articles were selected from a MEDLINE search for the period January 1966 to June 1995. Forty-nine studies were included in the metaanalysis. Results: The effect sizes for antidepressant treatment are moderately larger than for placebo. A larger effect size was observed in studies where objective diagnostic criteria for depression were used. Conclusions: We conclude that the superior efficacy of antidepressants over placebo can be demonstrated.
引用
收藏
页码:613 / 616
页数:4
相关论文
共 50 条
  • [21] Antidepressant agents for the treatment of chronic pain and depression
    Jann, Michael W.
    Slade, Julian H.
    PHARMACOTHERAPY, 2007, 27 (11): : 1571 - 1587
  • [22] Cognitive role of neurogenesis in depression and antidepressant treatment
    Perera, Tarique D.
    Park, Sungshic
    Nemirovskaya, Yelena
    NEUROSCIENTIST, 2008, 14 (04) : 326 - 338
  • [23] Effects of antidepressant treatment on sleep EEG in depression
    Armitage, R
    JOURNAL OF PSYCHOPHARMACOLOGY, 1996, 10 : 22 - 25
  • [24] A Precision Medicine Approach to Antidepressant Treatment in Depression
    Dawson, Gerard R.
    Kingslake, Jonathan
    Dourish, Colin T.
    Brammer, Mick
    Harmer, Catherine J.
    Goodwin, Guy M.
    Browning, Michael
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 215S - 215S
  • [25] IS PLATELET IMIPRAMINE BINDING REDUCED IN DEPRESSION - A METAANALYSIS
    ELLIS, PM
    SALMOND, C
    BIOLOGICAL PSYCHIATRY, 1994, 36 (05) : 292 - 299
  • [26] Depression and antidepressant treatment: from neurotoxicity to neurogenesis
    Radtchenko, A.
    Granger, B.
    Debray, Q.
    PSN-PSYCHIATRIE SCIENCES HUMAINES NEUROSCIENCES, 2009, 7 (3-4): : 145 - 151
  • [27] The risks and benefits of antidepressant treatment for youth depression
    Bridge, JA
    Salary, CB
    Birmaher, B
    Asare, AG
    Brent, DA
    ANNALS OF MEDICINE, 2005, 37 (06) : 404 - 412
  • [28] METAANALYSIS OF THE EFFICACY AND TOLERABILITY OF THE TRICYCLIC ANTIDEPRESSANT LOFEPRAMINE
    KERIHUEL, JC
    DREYFUS, JF
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1991, 19 (03) : 183 - 201
  • [29] Relationships between circadian measures, depression, and response to antidepressant treatment: A preliminary investigation
    Swanson, Leslie M.
    Burgess, Helen J.
    Huntley, Edward D.
    Bertram, Holli
    Mooney, Ann
    Zollars, Jennifer
    Dopp, Richard
    Hoffmann, Robert
    Armitage, Roseanne
    Arnedt, J. Todd
    PSYCHIATRY RESEARCH, 2017, 252 : 262 - 269
  • [30] Evaluating the association between antidepressant dose trajectories and treatment augmentation in pediatric depression
    Spence, O'Mareen
    Reeves, Gloria
    dosReis, Susan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (02) : 176 - 186